Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Vitamin D
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Recipient : Taipei Medical University
Deal Size : Inapplicable
Deal Type : Inapplicable
Vitamin D Supplementation in Healthy Adults in Prolonged Endurance Exercise
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
March 23, 2023
Lead Product(s) : Vitamin D
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Recipient : Taipei Medical University
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Vitamin D
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Recipient : Taipei Medical University
Deal Size : Inapplicable
Deal Type : Inapplicable
Vitamin D in Healthy Adults After Strenuous Endurance Exercise
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
March 22, 2023
Lead Product(s) : Vitamin D
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Recipient : Taipei Medical University
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Lepidium Meyenii
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Recipient : Taipei Medical University
Deal Size : Inapplicable
Deal Type : Inapplicable
Maca in Healthy Subjects After Strenuous Endurance Exercise
Details : Undisclosed
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
March 22, 2023
Lead Product(s) : Lepidium Meyenii
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Recipient : Taipei Medical University
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Ferric Citrate
Therapeutic Area : Nephrology
Study Phase : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
PBF-1681 (Ferric Citrate) for the Treatment of IDA in Patients With NDD-CKD
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
September 10, 2020
Lead Product(s) : Ferric Citrate
Therapeutic Area : Nephrology
Highest Development Status : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Ferric Citrate
Therapeutic Area : Nephrology
Study Phase : Phase III
Sponsor : SHANDONG WEIGAO GROUP
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
June 13, 2019
Lead Product(s) : Ferric Citrate
Therapeutic Area : Nephrology
Highest Development Status : Phase III
Sponsor : SHANDONG WEIGAO GROUP
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Ferric Citrate
Therapeutic Area : Nephrology
Study Phase : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
August 22, 2017
Lead Product(s) : Ferric Citrate
Therapeutic Area : Nephrology
Highest Development Status : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Ferric Citrate
Therapeutic Area : Nephrology
Study Phase : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
January 04, 2012
Lead Product(s) : Ferric Citrate
Therapeutic Area : Nephrology
Highest Development Status : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable